Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Premal H. Thaker, M.D
Washington University School of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chum
Montreal, Canada
- University of Alabama Birmingham
Birmingham, Alabama, United States
- Mitchell Cancer Institute (university of South Alabama)
Mobile, Alabama, United States
- Gynecologic Oncology Associates (hoag Hospital)
Newport Beach, California, United States
- Innovative Clinical Research
Whittier, California, United States
- Advent Health
Orlando, Florida, United States
- Women'S Care Florida
St. Petersburg, Florida, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
- Md Anderson at Cooper
Camden, New Jersey, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Monter Cancer Center
Lake Success, New York, United States
- Nyu Langone, Long Island
Mineola, New York, United States
- Nyu Langone
New York, New York, United States
- Stephenson Cancer Center - Oklahoma University
Oklahoma City, Oklahoma, United States
- Providence Cancer Institute
Portland, Oregon, United States
- Sanford Health
Sioux Falls, South Dakota, United States
- Chattanooga Women'S Health
Chattanooga, Tennessee, United States
- the West Clinic
Germantown, Tennessee, United States
- Providence Health Care
Spokane, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Sept 2018
- Primary completion
- 25 Jul 2024
- Completion
- 30 May 2026
- Last update posted
- 4 May 2026
- Registered enrollment
- 130
- Registry id
- NCT03393884
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.